Touch Briefings
Drug Development – Volume 5
In the latest issue David M Vulcano contributes an excellent paper, ‘The ‘New Normal’ of Regulatory Oversight of Clinical Investigators,’ while Axel K Olsen and Matthew D Whalen discuss ‘A Prescription for Industry – Risk Evaluation and Mitigation Strategy and Safety as a Paradigm.’ Elsewhere in this edition, Julian C Matthews provides a fascinating exploration of Positron Emission Tomography in clinical drug development.
Directed by an Advisory Board comprising internationally respected professionals, Drug Development’s articles endeavour to provide a concise and timely update on the latest opinion and advances spanning the breadth of drug development practice.
CDISC access the current edition, Drug Development – Volume 5 in full and for free in eBook format.
Health Sciences Visions from Touch Briefings
‘Touch Briefings announces launch of a new eHealthcare report — Patient Management without Walls'
The articles featured in this report view the changing healthcare ecosystem—focusing on how the move toward patient-centric systems will be technology led. Data connectivity will reduce complexity, drive efficiency, and improve patient outcomes. Here, we present a series of case studies by key thought leaders and an interview from the healthcare provider perspective:
- eHealthcare—Charting the Future Healthcare Prognosis
- Healthcare Without Walls—Delivering the Future Paradigm
- Building Connectivity, Interoperability, and Communication in eHealthcare— The Healthcare Provider Perspective
- Breaking Down the Walls of Healthcare
Pharmaceutical Business Review
CDISC is pleased to collaborate with Pharmaceutical Business Review (PBR). PBR websites have all the latest news, comment and industry information. Each Business Review website offers content that is produced by a dedicated team of journalists and global industry experts.
In addition to the free content made available on the sites an intelligence store will provide you with premium market analysis reports from the leading global suppliers of market research and industry analysis.
Pharmaceutical Business Review
